Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology
Kaoisung, Taiwan
General hospital in Kaohsiung
No. 123號, Dapi Rd, Niaosong District, Kaohsiung City, 833
About Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology
"Kaohsiung CGMH NeuroScience Lab MRI and PET schedule"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Clinical Trials at Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology
During the past decade, Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
2021-02-23
2025-04-15
Recruiting
270
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
2020-09-28
2025-06-27
Recruiting
750
A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide in Patients With Follicular Lymphoma After at Least One Line of Systemic Therapy
2021-10-27
2029-05-01
Recruiting
400
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology
According to Clinical.Site data, the most researched conditions in "Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology" are
"Diffuse Large B-cell Lymphoma" (1 trials), "Esophageal Squamous Cell Carcinoma" (1 trials) and "Relapsed or Refractory Follicular Lymphoma" (1 trials). Many other conditions were trialed in "Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology
Most popular intervention types in "Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Atezolizumab Matching Placebo" (1 trials), "Gemcitabine" (1 trials), "Glofitamab" (1 trials) and "Lenalidomide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology
The vast majority of trials in "Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology" are
3 trials for "All" genders.
Clinical Trials Status at Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology
Currently, there are NaN active trials in "Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".